Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

NCT00671801 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Toxicity

Conditions

Malignant Gliomas

Interventions

DRUG: Irinotecan
DRUG: Lenalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]